CD40 and autoimmunity: the dark side of a great activator.
about
CD154: an immunoinflammatory mediator in systemic lupus erythematosus and rheumatoid arthritisFollicular helper T cells in immunity and systemic autoimmunityCD40 in coronary artery disease: a matter of macrophages?The Contribution of CD40/CD40L Axis in Inflammatory Bowel Disease: An UpdateCD40 gene silencing reduces the progression of experimental lupus nephritis modulating local milieu and systemic mechanismsRepetitive hyperbaric oxygenation attenuates reactive astrogliosis and suppresses expression of inflammatory mediators in the rat model of brain injuryInhibition of CD40-TRAF6 interactions by the small molecule inhibitor 6877002 reduces neuroinflammation.HIF1A (rs11549465) and AKNA (rs10817595) Gene Polymorphisms Are Associated with Primary Sjögren's Syndrome.Simultaneous assessment of rotavirus-specific memory B cells and serological memory after B cell depletion therapy with rituximab.CD40: novel association with Crohn's disease and replication in multiple sclerosis susceptibilityAnti-nucleocapsid protein immune responses counteract pathogenic effects of Rift Valley fever virus infection in mice.Costimulatory pathways in transplantation.CD40L deficiency attenuates diet-induced adipose tissue inflammation by impairing immune cell accumulation and production of pathogenic IgG-antibodies.Analysis of the association between CD40 and CD40 ligand polymorphisms and systemic sclerosis.Study of association of CD40-CD154 gene polymorphisms with disease susceptibility and cardiovascular risk in Spanish rheumatoid arthritis patients.CD40-mediated amplification of local immunity by epithelial cells is impaired by HPV.Differential TRAF3 utilization by a variant human CD40 receptor with enhanced signalingProinflammatory responses induced by CD40 in retinal endothelial and Müller cells are inhibited by blocking CD40-Traf2,3 or CD40-Traf6 signaling.CD40 promotes the development of early diabetic retinopathy in miceCD40 polymorphisms in Han Chinese patients with Fuch uveitis syndrome.TNF superfamily protein-protein interactions: feasibility of small- molecule modulationRegulation of Autocrine Signaling in Subsets of Sympathetic Neurons Has Regional Effects on Tissue Innervation.Immunoglobulin M levels inversely correlate with CD40 ligand promoter methylation in patients with primary biliary cirrhosis.Decreased Frequency of Circulating Myelin Oligodendrocyte Glycoprotein B Lymphocytes in Patients with Relapsing-Remitting Multiple Sclerosis.TNF superfamily in inflammatory disease: translating basic insights.CD40-CD40 Ligand Pathway is a Major Component of Acute Neuroinflammation and Contributes to Long-term Cognitive Dysfunction after Sepsis.Expression, purification and biological characterization of the extracellular domain of CD40 from Pichia pastorisApoptotic marginal zone deletion of anti-Sm/ribonucleoprotein B cellsThe Interaction of CD154 with the α5β1 Integrin Inhibits Fas-Induced T Cell DeathCD40 Expression in Fibrocytes Is Induced by TSH: Potential Synergistic Immune Activation.Increased CD40 Expression Enhances Early STING-Mediated Type I Interferon Response and Host Survival in a Rodent Malaria Model.Genetically driven target tissue overexpression of CD40: a novel mechanism in autoimmune disease.Effects of sensor-augmented pump therapy on glycemic variability in well-controlled type 1 diabetes in the STAR 3 study.Interleukin-6 production in CD40-engaged fibrocytes in thyroid-associated ophthalmopathy: involvement of Akt and NF-κB.Mechanistic basis of immunotherapies for type 1 diabetes mellitusConstitutively CD40-activated B cells regulate CD8 T cell inflammatory response by IL-10 inductionAgonistic anti-CD40 induces thyrocyte proliferation and promotes thyroid autoimmunity by increasing CD40 expression on thyroid epithelial cells.Clinical targeting of the TNF and TNFR superfamiliesNanovesicle-targeted Kv1.3 knockdown in memory T cells suppresses CD40L expression and memory phenotype.T cells interact with T cells via CD40-CD154 to promote autoimmunity in type 1 diabetes.
P2860
Q21285053-9736519F-64FC-4DF6-90B9-B9A92EF363E9Q24600825-D342517E-ED86-400F-9F1D-1FA5568C97A9Q26752784-79BF9F73-394A-42F5-B2C4-583F7E05B2E5Q26777192-EE841DE7-300E-4FB4-B61D-9700C6C38844Q28533954-D1BB2258-4C8F-4226-99F9-5AC78E8A2AB1Q28570194-EC3BD6BE-5620-4EB4-A372-86B1BC383916Q30849102-01A27349-F4BA-443A-958D-4612D1B94AEAQ33581766-0968DAA8-DC11-4B31-9252-0C09906AB0D8Q33599297-66E54DB8-0C4A-47D4-875B-413EC9B45CC3Q33633981-EC7C7581-A1F8-401E-8D0B-8A78A6CC046EQ34031858-48182F07-8E70-4C75-88ED-7B6C7A16042BQ34187594-2BD9B443-AEBA-4E09-8398-46ACACB3AE42Q34193651-6CB2106E-F3B9-4039-BA31-2D72DB2EBAC6Q34283946-5BCE4816-2A52-4D9E-BA73-B3F3BF982BA5Q34482096-0A68A379-7F89-4389-A448-2855A1F100F4Q34488528-77BC3B9A-0001-426B-96BE-9416F2739599Q34580224-0806ADFA-C3A9-4E72-BD92-6B9D3E79BDEFQ34795130-C8292D64-165D-4280-94CA-CFB64CE11372Q34919840-7C0D6BD3-BA80-42A6-9E86-A81D583102F8Q35255238-FD541C1F-2AEA-4406-9720-A0B2336E2320Q35534271-BF748D32-DDA1-45CE-B60E-D198741F7BAFQ35574017-4E3258DD-D3A9-4316-BC71-01307BAD66D5Q35631675-078926E1-F17E-48E5-99FF-2443145A2ED3Q35674246-7A4F5ED6-F7FF-4751-B7E0-A8E0ED603142Q35821666-44F5404F-0FC5-4F31-AD2D-AD1558D274C4Q35855669-0D9AF7D4-4621-45C7-8167-C7064D16FBBBQ35904275-04071173-F6C8-4D56-879B-B18924AAFBE2Q35974118-E8777F36-B650-4E8E-AB58-468F2ADF2924Q36070900-BAED2F49-36F6-48B3-906C-B32412869D92Q36133982-787F7429-98F2-482C-B668-48EF1032B5A2Q36157771-F2691B4D-26A8-4FA0-A9F4-33E0C69C22A5Q36218526-2A19D1AF-A7C8-4486-B8A5-C85B04EA406FQ36417410-72A07DC8-E168-48F4-B0CF-0229D748E304Q36422528-0E659FF5-4054-42E5-A75C-EF7A1BC2E949Q36698793-9D8946A4-989D-45E4-BF94-AD65EC0FB0F8Q36718160-26E38DA7-4B1A-44D4-9362-AA8354D1C4E6Q36754417-3BD909EF-B89F-41C3-87EC-9BC8883C8638Q36762882-05422685-5D59-4C5A-8D86-C19BA22E95D8Q36794555-794CB80E-E28B-40BF-A57A-72DAF5D7711DQ36971881-6D7332E2-C8EE-46CE-B7EF-6D70105C5056
P2860
CD40 and autoimmunity: the dark side of a great activator.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
CD40 and autoimmunity: the dark side of a great activator.
@en
CD40 and autoimmunity: the dark side of a great activator.
@nl
type
label
CD40 and autoimmunity: the dark side of a great activator.
@en
CD40 and autoimmunity: the dark side of a great activator.
@nl
prefLabel
CD40 and autoimmunity: the dark side of a great activator.
@en
CD40 and autoimmunity: the dark side of a great activator.
@nl
P2860
P1476
CD40 and autoimmunity: the dark side of a great activator
@en
P2093
Anna L Peters
Laura L Stunz
P2860
P304
P356
10.1016/J.SMIM.2009.05.012
P577
2009-10-01T00:00:00Z